Back
EyePoint Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
EYPT
EyePoint Pharmaceuticals
Last Price:
8.94
Seasonality Move:
28.93%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.31 | Sell |
| 20-day SMA: | 10.76 | Sell |
| 50-day SMA: | 9.77 | Sell |
| 200-day SMA: | 13.45 | Sell |
| 8-day EMA: | 9.35 | Sell |
| 20-day EMA: | 10.02 | Sell |
| 50-day EMA: | 9.94 | Sell |
| 200-day EMA: | 11.46 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 41.34 | Sell |
| Chaikin Money Flow: | 378625 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.4 - 11.84) | Sell |
| Bollinger Bands (100): | (8.13 - 10.51) | Sell |
EyePoint Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 8.95 while EYPT 8-day simple moving average is 9.31, which is a Sell signal.
- The stock price of EYPT is 8.95 while EyePoint Pharmaceuticals 20-day SMA is 10.76, which makes it a Sell.
- EyePoint Pharmaceuticals 50-day simple moving average is 9.77 while EYPT share price is 8.95, making it a Sell technically.
- EYPT stock price is 8.95 and EyePoint Pharmaceuticals 200-day simple moving average is 13.45, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Buy
61
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a Buy
The current EyePoint Pharmaceuticals [EYPT] share price is $8.95. The Score for EYPT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
610.85M
Price in USD:
8.95
Share Volume:
1.1M
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
30.99
52-Week Low:
5.87
Buy
61
EyePoint Pharmaceuticals (EYPT)
is a Buy
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?
The EyePoint Pharmaceuticals stock price is 8.95 USD today. -
Will EYPT stock go up or go down?
EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is EyePoint Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is not overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 8.95 while EYPT 8-day exponential moving average is 9.35, which is a Sell signal.
- The stock price of EYPT is 8.95 while EyePoint Pharmaceuticals 20-day EMA is 10.02, which makes it a Sell.
- EyePoint Pharmaceuticals 50-day exponential moving average is 9.94 while EYPT share price is 8.95, making it a Sell technically.
- EYPT stock price is 8.95 and EyePoint Pharmaceuticals 200-day simple moving average is 11.46, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
- EYPT Moving Average Covergence Divergence (MACD) indicator is -0.37, suggesting EyePoint Pharmaceuticals is a Sell
- EyePoint Pharmaceuticals Relative Strength Index (RSI) is 41.34, which suggest EyePoint Pharmaceuticals is oversold
- The Bollinger Bands (25) for EyePoint Pharmaceuticals is (9.4 - 11.84), which suggest EyePoint Pharmaceuticals is a Sell
- The Bollinger Bands (100) for EyePoint Pharmaceuticals is (8.13 - 10.51), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.